🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single institution study of combining decitabine with fludarabine...
Status
Completed
Location
Hackensack University Medical Center - John Theurer Cancer Center
Start Date
2009-05
Trial ID
NCT01455506
Treatments Being Tested
The prognosis for older individuals with acute myelogenous leukemia (AML) h...
Status
Completed
Location
University of Michigan Cancer Center
Start Date
2007-03
Trial ID
NCT00623935
Treatments Being Tested
This pilot clinical trial studies the side effects and best dose of ruxolit...
Status
Completed
Location
City of Hope Medical Center
Start Date
2016-11-13
Trial ID
NCT02917096
One of the possible options for the treatment of MS at present is a high-do...
Status
Recruiting
Location
First Pavlov State Medical University of St. Petersburg
Start Date
2020-10-01
Trial ID
NCT05832515
Treatments Being Tested
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
This is a patient-sponsored study that evaluates the safety and efficacy of...
Status
Unknown
Location
Makati Medical Center
Start Date
2015-05-29
Trial ID
NCT03113162
Treatments Being Tested
Giving chemotherapy drugs, such as fludarabine and busulfan, before a donor...
Status
Completed
Location
University of California Davis Cancer Center
Start Date
2007-06
Trial ID
NCT00619645
This is a Phase II, open-label, two strata, multicenter, prospective study ...
Status
Completed
Location
H. Lee Moffitt Cancer Center
Start Date
2013-05
Trial ID
NCT01696461
Treatments Being Tested
This is a research study involving the treatment of patients with hematolog...
Status
Terminated
Location
Thomas Jefferson University
Start Date
2011-04
Trial ID
NCT01350258
RATIONALE: - Relapsed or refractory Neuroblastoma (NBL) carries a very poor...
Status
Withdrawn
Location
Children's Memorial Hospital
Start Date
2008-09
Trial ID
NCT00874315